AF
BLFS icon

Amalgamated Financial’s BioLife Solutions BLFS Stock Holding History

Amalgamated Financial’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$255K Buy
+11,216
New +$295K ﹤0.01% 1798

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Amalgamated Financial's BLFS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in BioLife Solutions (BLFS) in Q1 2022: 11,216 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #1798 among its holdings.

164 funds tracked by Wall St. Rank hold BLFS as of Q1 2022.

  • Amalgamated Financial held 11,216 shares of BioLife Solutions worth $255K as of Q1 2022.
  • BioLife Solutions was a new Amalgamated Financial position in Q1 2022.
  • BioLife Solutions made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1798 holding.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.